HappeningToo topic
Omalizumab reports
Browse community reports connected to Omalizumab. These reports can show that other people are describing similar experiences, but they do not prove that Omalizumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
37 problems
Abdominal Pain Upper while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and abdominal pain upper appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and abdominal pain appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and acid reflux appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and alopecia appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and anxiety appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and back pain appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and chest discomfort appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and chills appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and cough appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and diarrhea appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and dizziness appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and fatigue appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and feeling abnormal appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and headache appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and heart rate increased appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and hives appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Influenza Like Illness while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and influenza like illness appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and insomnia appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and itching appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and malaise appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and migraine appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and muscle spasms appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and myalgia appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and nausea appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Oropharyngeal Pain while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and oropharyngeal pain appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and pain appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and peripheral swelling appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and rash appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and shortness of breath appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and skin redness appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and sleepiness appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and swelling appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and tingling or pins and needles appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and vomiting appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and weakness appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and weight decreased appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Omalizumab
FDA FAERS contains adverse-event reports in which Omalizumab and weight increased appear together. This does not establish that Omalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →